Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 2010 Oct 1;120(10):3735. doi: 10.1172/JCI42551C1

Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity

Joseph Tam, V Kiran Vemuri, Jie Liu, Sándor Bátkai, Bani Mukhopadhyay, Grzegorz Godlewski, Douglas Osei-Hyiaman, Shinobu Ohnuma, Suresh V Ambudkar, James Pickel, Alexandros Makriyannis, George Kunos
PMCID: PMC2947226

Original citation: J Clin Invest. 2010;120(8):2953–2966. doi:10.1172/JCI42551.

Citation for this corrigendum: J Clin Invest. 2010;120(10):3735. doi:10.1172/JCI42551C1.

In Figure 3E, the units provided for carbohydrate oxidation and fat oxidation were incorrect. The units for both should be g/d/kg0.75.

The authors regret the error.


Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES